FranΓ§aisπ See the interactive version (live chart) β
For Amn Healthcare Services, Inc., we replayed every analyst price target of the past 12 months and measured the real outcome: 27% were profitable, average return -2% (75 calls). At 3 months: +0% average return (42% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| BMO Capital | 19 | 21% | -14% |
| Credit Suisse | 13 | 31% | +14% |
| Truist Securities | 11 | 0% | -30% |
| JMP Securities | 10 | 10% | -36% |
| Benchmark | 7 | 14% | +3% |
The analyst consensus on Amn Healthcare Services, Inc. (AMN) is "Buy" (10 bullish, 1 bearish calls over 12 months). This is not advice: historically, 27% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $35.00 (-0% vs $35.08), ranging from $26.00 to $40.00 (5 analysts).
Over 1 year, 27% of analyst targets on Amn Healthcare Services, Inc. were profitable, for an average return of -2% (across 75 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $35.00 within 12 months, i.e. -0% vs the current price. The most bullish targets $40.00, the most cautious $26.00.
Note: analyst targets are 12-month (median $35.00, -0%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (27%), and the stock's past trajectory.
Detailed valuation data for Amn Healthcare Services, Inc. is available in the interactive analysis.
π See the full interactive analysis of Amn Healthcare Services, Inc. β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.